文献速递贫血与红细胞疾病

妊娠期与产褥期自身免疫性溶血性贫血:一项国际多中心经验

Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience.
PubMed 文献 · Blood · 2023-01-01

该研究报道了1997至2022年间12个中心33例女性的45次妊娠,其中20例孕前已诊断自身免疫性溶血性贫血(AIHA)者10例复发,另13例在妊娠/产褥期新发AIHA。24次溶血事件中贫血均严重(中位Hb 6.4 g/dL,范围3.1-8.7),全部需要治疗,所有患者均获得缓解,65%为完全缓解。母体并发症发生率为15%,早期流产13%,胎儿不良事件22%。结论认为,只要密切监测、及时治疗并意识到潜在的母胎并发症,发生AIHA并不妨碍顺利妊娠。

要点

  • 孕前已诊断AIHA的20例女性中10例在妊娠期复发。
  • 24次溶血事件贫血均严重,中位Hb 6.4 g/dL(范围3.1-8.7),全部需要治疗。
  • 所有患者均获得缓解,65%为完全缓解;母体并发症发生率15%,胎儿不良事件22%。

核心结论

  • 发生AIHA并不妨碍顺利妊娠,前提是密切监测、及时治疗并意识到潜在的母体和胎儿并发症。

研究设计与样本

  • 国际多中心研究,纳入1997至2022年间12个中心的33例女性共45次妊娠。

主要发现

  • 20例孕前已诊断AIHA的女性中10例复发,另13例在妊娠/产褥期新发AIHA(其中2例在第二次妊娠时复发)。
  • 24次溶血事件中贫血均严重,中位Hb 6.4 g/dL(范围3.1-8.7),全部需要治疗:96%使用类固醇±静脉注射免疫球蛋白(IVIG),58%接受输血。
  • 所有患者均获得缓解,65%的病例为完全缓解;8例(33%)接受了抗血栓预防。
  • 分娩后4例接受利妥昔单抗,1例加用环孢素。
  • 母体并发症(包括胎膜早破、胎盘早剥和子痫前期)发生率为15%;早期流产发生于13%的妊娠;胎儿不良事件(22%的病例)包括呼吸窘迫、胎儿生长受限、早产、新生儿AIHA和2例围产期死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Relapsing or occurring de novo autoimmune hemolytic anemia (AIHA) during pregnancy or puerperium is a poorly described condition. Here, we report 45 pregnancies in 33 women evaluated at 12 centers from 1997 to 2022. Among the 20 women diagnosed with AIHA before pregnancy, 10 had a relapse. An additional 13 patients developed de novo AIHA during gestation/puerperium (2 patients had AIHA relapse during a second pregnancy). Among 24 hemolytic events, anemia was uniformly severe (median Hb, 6.4 g/dL; range, 3.1-8.7) and required treatment in all cases (96% steroids ± intravenous immunoglobulin, IVIG, 58% transfusions). Response was achieved in all patients and was complete in 65% of the cases. Antithrombotic prophylaxis was administered to 8 patients (33%). After delivery, rituximab was administered to 4 patients, and cyclosporine was added to 1 patient. The rate of maternal complications, including premature rupture of membranes, placental detachment, and preeclampsia, was 15%. Early miscarriages occurred in 13% of the pregnancies. Fetal adverse events (22% of cases) included respiratory distress, fetal growth restriction, preterm birth, AIHA of the newborn, and 2 perinatal deaths. In conclusion, the occurrence of AIHA does not preclude the ability to carry out a healthy pregnancy, provided close monitoring, prompt therapy, and awareness of potential maternal and fetal complications.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Fattizzo B, Bortolotti M, Fantini NN, et al. Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience. Blood. 2023. PMID: 36706358. doi:10.1182/blood.2022018890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。